Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
e.l.f. Beauty
ELF
|
+$676M |
| 2 |
UnitedHealth
UNH
|
+$402M |
| 3 |
AutoZone
AZO
|
+$339M |
| 4 |
Kaspi.kz JSC
KSPI
|
+$269M |
| 5 |
Enphase Energy
ENPH
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.12B |
| 2 |
Spotify
SPOT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$619M |
| 4 |
Teradyne
TER
|
+$540M |
| 5 |
Shopify
SHOP
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.35% |
| 2 | Technology | 27.26% |
| 3 | Communication Services | 14.16% |
| 4 | Healthcare | 13.89% |
| 5 | Financials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKYT
226
DELISTED
SkyWater Technology
SKYT
| $7.71M | 0.01% |
1,007,449
+42,649
| +4% | +$370K |
|
227
FTI Consulting
FCN
$4.18B
| $6.83M | 0.01% |
31,692
| – | – |
|
228
Cardlytics
CDLX
$21.5M
| $6.81M | 0.01% |
82,927
-10,982
| -12% | -$1.19M |
|
229
MongoDB
MDB
$32.1B
| $6.62M | 0.01% |
26,477
| – | – |
|
230
Freshpet
FRPT
$3.22B
| $6.47M | 0.01% |
50,013
+344
| +0.7% | +$41.3K |
|
231
Globus Medical
GMED
$11.2B
| $6.24M | ﹤0.01% |
91,084
+18
| +0% | +$1.07K |
|
232
EOG Resources
EOG
$70.7B
| $5.56M | ﹤0.01% |
44,208
| – | – |
|
233
Albemarle Corp Depositary Shares
ALB.PRA
$2.64B
| $5.48M | ﹤0.01% |
120,000
| – | – |
|
234
Sutro Biopharma
STRO
$421M
| $5.42M | ﹤0.01% |
184,875
+184
| +0.1% | +$7.28K |
|
235
Savers
SVV
$1.88B
| $5M | ﹤0.01% |
+408,533
| New | +$6.1M |
|
236
GitLab
GTLB
$6.58B
| $4.64M | ﹤0.01% |
93,382
+18
| +0% | +$935 |
|
237
Zillow
ZG
$7.63B
| $4.09M | ﹤0.01% |
90,705
-33,833
| -27% | -$1.46M |
|
238
Exelon
EXC
$47B
| $3.31M | ﹤0.01% |
95,638
| – | – |
|
239
Health Catalyst
HCAT
$128M
| $2.75M | ﹤0.01% |
430,597
-106,171
| -20% | -$682K |
|
240
CenterPoint Energy
CNP
$26.8B
| $2.44M | ﹤0.01% |
78,838
+12,422
| +19% | +$367K |
|
241
Coinbase
COIN
$40.5B
| $2.33M | ﹤0.01% |
10,484
+2
| +0% | +$460 |
|
242
Medpace
MEDP
$16.5B
| $2.22M | ﹤0.01% |
+5,398
| New | +$2.14M |
|
243
SharkNinja
SN
$26.1B
| $2.11M | ﹤0.01% |
+28,048
| New | +$1.98M |
|
|
AKLI
244
DELISTED
Akili Inc
AKLI
| $2.03M | ﹤0.01% |
4,665,795
| – | – |
|
245
Relay Therapeutics
RLAY
$4.33B
| $1.85M | ﹤0.01% |
284,058
-69,168
| -20% | -$473K |
|
246
Southern Company
SO
$107B
| $1.72M | ﹤0.01% |
22,231
+4,731
| +27% | +$359K |
|
247
Expensify
EXFY
$245M
| $1.62M | ﹤0.01% |
1,087,405
+392
| +0% | +$618 |
|
|
GOOS
248
Canada Goose Holdings
GOOS
$856M
| $1.54M | ﹤0.01% |
119,221
| – | – |
|
249
Equity Residential
EQR
$25.1B
| $1.37M | ﹤0.01% |
19,715
+2,246
| +13% | +$146K |
|
|
CLLS
250
Cellectis
CLLS
$285M
| $1.32M | ﹤0.01% |
707,630
-119,618
| -14% | -$314K |
|
Similar funds
Baillie Gifford & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Baillie Gifford & Co held 303 positions worth $128B, down 0.15% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Baillie Gifford & Co withdrew a net $5.32B in Q2 2024, closing 18 positions and reducing 164 holdings. Its most notable exit was Baidu, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Baillie Gifford & Co opened a new position in e.l.f. Beauty worth $802M.
- Baillie Gifford & Co's largest Q2 2024 buy was e.l.f. Beauty: 3,804,541 shares worth $802M.
- Baillie Gifford & Co added most to UnitedHealth in Q2 2024, an estimated $402M increase.
- Baillie Gifford & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.12B.
- Baillie Gifford & Co fully exited Baidu in Q2 2024, selling an estimated $271M.
- Baillie Gifford & Co's ten largest holdings make up 42% of its $128B portfolio in Q2 2024.
- Baillie Gifford & Co opened 13 new positions and closed 18 in Q2 2024.
- Baillie Gifford & Co's portfolio value fell 0.15% quarter-over-quarter to $128B.
Based on Baillie Gifford & Co's 13F filing for Q2 2024, filed 25 Jul 2024.